Fabtech Technologies Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Attractively valued vs sector (P/E 18.5x vs industry 54.4x)
- ✓Low debt relative to equity (D/E 0.2x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Corporate Events
To consider dividend for the Financial Year ended March 31, 2026.
To consider and approve the financial results for the period ended March 31, 2026
Latest News
All news →Fabtech Technologies acquires undisclosed business for growth
*Fabtech Technologies acquires undisclosed business for growth.* The company aims to expand its operational footprint and diversify revenue streams. The acquisition value and target remain undisclosed. Integration is expected to be completed within **6–8 months**. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #Acquisition
Fabtech Technologies announces change in management
*Fabtech Technologies announces change in management* — The company has disclosed a leadership transition following a corporate filing with the NSE. No further details on outgoing or incoming executives were provided. Such changes may influence strategic direction and investor sentiment. \n\n 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #MEDIUMIMPACT #ManagementChange
Fabtech Technologies announces board meeting outcomes.
*Fabtech Technologies announces board meeting outcomes.* The company disclosed outcomes from its June 25, 2026, board meeting via a filing. No major strategic decisions or financial announcements were detailed. The update is routine in nature with no immediate market-moving implications. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #CorporateUpdate
Fabtech Technologies announces board meeting outcomes.
*Fabtech Technologies announces outcomes from its recent board meeting.* No major financial or strategic decisions disclosed. Event reflects routine corporate governance. Details remain limited to compliance filing. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #BoardMeeting
Fabtech Technologies shares: Shareholder voting results disclosed
*Fabtech Technologies shares: Shareholder voting results disclosed.* The company shared the scrutinizers report and voting outcomes of its postal ballot with the exchange. **No major financial or strategic changes** were indicated in the filing. The update is procedural and does not signal immediate market-moving developments. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #ShareholderMeeting
Fabtech Technologies hosts analyst and investor meet
*Fabtech Technologies hosts analyst and investor meet* to discuss business updates and strategic outlook. The company provided insights during the con-call with institutional investors. No major announcements or financial revisions were disclosed. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #InvestorMeet
Fabtech Technologies to host analyst and investor meet.
*Fabtech Technologies to host analyst and investor meet.* The company has scheduled a conference call for institutional investors and analysts. Details are part of a recent NSE filing. No financial updates or major announcements were disclosed. 📊 *STOCKS:* FABTECH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #InvestorMeet
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹159 Cr ▲152.4% | ₹63 Cr ▼47.9% | ₹121 Cr ▲77.9% | ₹68 Cr ▼49.6% | ₹135 Cr ▲29.8% | ₹104 Cr ▲76.3% | ₹59 Cr |
| Op. Profit | ₹22 Cr ▲283.3% | ₹-12 Cr ▼140.0% | ₹30 Cr ▲600.0% | ₹-6 Cr ▼133.3% | ₹18 Cr ▼21.7% | ₹23 Cr ▲360.0% | ₹5 Cr |
| OPM | 14.0% ▲177.8% | -18.0% ▼172.0% | 25.0% ▲377.8% | -9.0% ▼164.3% | 14.0% ▼36.4% | 22.0% ▲175.0% | 8.0% |
| Net Profit | ₹22 Cr ▲466.7% | ₹-6 Cr ▼121.4% | ₹28 Cr ▲566.7% | ₹-6 Cr ▼140.0% | ₹15 Cr ▼25.0% | ₹20 Cr ▲300.0% | ₹5 Cr |
| EPS (₹) | 4.96 ▲487.5% | -1.28 ▼114.7% | 8.68 ▲559.3% | -1.89 ▼140.6% | 4.66 ▼26.3% | 6.32 ▲300.0% | 1.58 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹411 Cr ▲25.7% | ₹327 Cr ▲44.7% | ₹226 Cr ▲16.5% | ₹194 Cr ▼24.5% | ₹257 Cr ▲112.4% | ₹121 Cr ▼9.0% | ₹133 Cr |
| Expenses | ₹376 Cr ▲30.6% | ₹288 Cr ▲50.8% | ₹191 Cr ▲13.0% | ₹169 Cr ▼24.9% | ₹225 Cr ▲104.5% | ₹110 Cr ▼7.6% | ₹119 Cr |
| Op. Profit | ₹35 Cr ▼10.3% | ₹39 Cr ▲11.4% | ₹35 Cr ▲40.0% | ₹25 Cr ▼21.9% | ₹32 Cr ▲190.9% | ₹11 Cr ▼21.4% | ₹14 Cr |
| OPM | 9.0% ▼25.0% | 12.0% ▼20.0% | 15.0% ▲15.4% | 13.0% ▲8.3% | 12.0% ▲33.3% | 9.0% ▼18.2% | 11.0% |
| Other Income | ₹23 Cr ▼14.8% | ₹27 Cr ▲350.0% | ₹6 Cr ▼40.0% | ₹10 Cr ▲150.0% | ₹4 Cr ▲100.0% | ₹2 Cr ▼60.0% | ₹5 Cr |
| Interest | ₹4 Cr ▲33.3% | ₹3 Cr ▲0.0% | ₹3 Cr ▼40.0% | ₹5 Cr ▲66.7% | ₹3 Cr ▲50.0% | ₹2 Cr ▲0.0% | ₹2 Cr |
| Depreciation | ₹5 Cr ▲66.7% | ₹3 Cr ▲50.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr | ₹0 Cr | ₹0 Cr |
| PBT | ₹48 Cr ▼20.0% | ₹60 Cr ▲66.7% | ₹36 Cr ▲28.6% | ₹28 Cr ▼9.7% | ₹31 Cr ▲181.8% | ₹11 Cr ▼31.3% | ₹16 Cr |
| Tax % | 21.0% ▼8.7% | 23.0% ▼4.2% | 24.0% ▲9.1% | 22.0% ▼12.0% | 25.0% ▼13.8% | 29.0% ▲7.4% | 27.0% |
| Net Profit | ₹38 Cr ▼17.4% | ₹46 Cr ▲70.4% | ₹27 Cr ▲22.7% | ₹22 Cr ▼4.3% | ₹23 Cr ▲187.5% | ₹8 Cr ▼33.3% | ₹12 Cr |
| EPS (₹) | 8.63 ▼39.8% | 14.34 ▼84.5% | 92.44 ▲18.5% | 78 ▼7.5% | 84.28 ▼99.0% | 8,040 ▼35.1% | 12,390 |
| Div Payout | 7.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||
| Equity Capital | ₹44 Cr ▲37.5% | ₹32 Cr ▲0.0% | ₹32 Cr ▲966.7% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▲29900.0% | ₹0.01 Cr ▲0.0% | ₹0.01 Cr |
| Reserves | ₹375 Cr ▲131.5% | ₹162 Cr ▲14.9% | ₹141 Cr ▲9.3% | ₹129 Cr ▲50.0% | ₹86 Cr ▲32.3% | ₹65 Cr ▲41.3% | ₹46 Cr ▲21.1% | ₹38 Cr |
| Borrowings | ₹70 Cr ▲66.7% | ₹42 Cr ▼50.0% | ₹84 Cr ▲546.2% | ₹13 Cr ▼62.9% | ₹35 Cr ▲66.7% | ₹21 Cr ▲133.3% | ₹9 Cr ▲800.0% | ₹1 Cr |
| Other Liabilities | ₹164 Cr ▼9.4% | ₹181 Cr ▲6.5% | ₹170 Cr ▲36.0% | ₹125 Cr ▲40.4% | ₹89 Cr ▲7.2% | ₹83 Cr ▲18.6% | ₹70 Cr ▼16.7% | ₹84 Cr |
| Total Liabilities | ₹654 Cr ▲56.5% | ₹418 Cr ▼2.1% | ₹427 Cr ▲58.7% | ₹269 Cr ▲25.7% | ₹214 Cr ▲24.4% | ₹172 Cr ▲36.5% | ₹126 Cr ▲2.4% | ₹123 Cr |
| Assets | ||||||||
| Fixed Assets | ₹78 Cr ▼1.3% | ₹79 Cr ▼16.0% | ₹94 Cr ▲327.3% | ₹22 Cr ▲450.0% | ₹4 Cr ▼20.0% | ₹5 Cr ▲150.0% | ₹2 Cr ▲0.0% | ₹2 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹26 Cr ▲4.0% | ₹25 Cr ▲66.7% | ₹15 Cr ▼28.6% | ₹21 Cr ▲5.0% | ₹20 Cr ▲17.6% | ₹17 Cr ▲142.9% | ₹7 Cr ▼41.7% | ₹12 Cr |
| Other Assets | ₹550 Cr ▲75.7% | ₹313 Cr ▼1.6% | ₹318 Cr ▲40.7% | ₹226 Cr ▲18.9% | ₹190 Cr ▲26.7% | ₹150 Cr ▲29.3% | ₹116 Cr ▲6.4% | ₹109 Cr |
| Total Assets | ₹654 Cr ▲56.5% | ₹418 Cr ▼2.1% | ₹427 Cr ▲58.7% | ₹269 Cr ▲25.7% | ₹214 Cr ▲24.4% | ₹172 Cr ▲36.5% | ₹126 Cr ▲2.4% | ₹123 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹0 Cr ▲100.0% | ₹-36 Cr ▼160.0% | ₹60 Cr ▲528.6% | ₹-14 Cr ▼366.7% | ₹-3 Cr ▲66.7% | ₹-9 Cr ▼114.1% | ₹64 Cr |
| Investing CF | ₹-112 Cr ▼460.0% | ₹-20 Cr ▲33.3% | ₹-30 Cr ▼1600.0% | ₹2 Cr ▲122.2% | ₹-9 Cr ▼325.0% | ₹4 Cr ▲114.3% | ₹-28 Cr |
| Financing CF | ₹190 Cr ▲427.8% | ₹36 Cr ▲400.0% | ₹-12 Cr ▼200.0% | ₹12 Cr ▲50.0% | ₹8 Cr ▲33.3% | ₹6 Cr ▲126.1% | ₹-23 Cr |
| Net Cash Flow | ₹78 Cr ▲490.0% | ₹-20 Cr ▼211.1% | ₹18 Cr | ₹0 Cr ▲100.0% | ₹-4 Cr ▼500.0% | ₹1 Cr ▼92.3% | ₹13 Cr |
| Free Cash Flow | ₹5 Cr ▲108.2% | ₹-61 Cr ▼203.4% | ₹59 Cr ▲521.4% | ₹-14 Cr ▼250.0% | ₹-4 Cr ▲55.6% | ₹-9 Cr ▼114.1% | ₹64 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 182d ▲8.3% | 168d ▲7.7% | 156d ▼16.6% | 187d ▲55.8% | 120d ▼11.1% | 135d ▲22.7% | 110d |
| Inventory Days | 32d ▼73.1% | 119d ▲35.2% | 88d ▲27.5% | 69d ▲305.9% | 17d ▼56.4% | 39d ▲77.3% | 22d |
| Days Payable | 159d ▼19.7% | 198d ▲1.5% | 195d ▼9.3% | 215d ▲58.1% | 136d ▼9.3% | 150d ▲82.9% | 82d |
| Cash Conv. Cycle | 55d ▼38.2% | 89d ▲81.6% | 49d ▲19.5% | 41d ▲4000.0% | 1d ▼96.0% | 25d ▼51.0% | 51d |
| Working Capital Days | 90d ▲69.8% | 53d ▼15.9% | 63d ▼3.1% | 65d ▲116.7% | 30d ▲100.0% | 15d ▲178.9% | -19d |
| ROCE | 14.0% ▼36.4% | 22.0% ▼21.4% | 28.0% ▼9.7% | 31.0% ▼35.4% | 48.0% ▲84.6% | 26.0% | — |
Source: Screener.in · Lower days = better efficiency
About Fabtech Technologies Limited
Incorporated in 2018, Fabtech Technologies Ltd is a biopharma engineering company.[1]
Healthcare · Healthcare Services